ID   OTCC_PSEAE              Reviewed;         336 AA.
AC   P08308;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   27-NOV-2024, entry version 176.
DE   RecName: Full=Ornithine carbamoyltransferase, catabolic {ECO:0000303|PubMed:4962140};
DE            Short=OTCase {ECO:0000303|PubMed:4962140};
DE            EC=2.1.3.3 {ECO:0000255|HAMAP-Rule:MF_01109};
GN   Name=arcB {ECO:0000303|PubMed:3109911}; OrderedLocusNames=PA5172;
OS   Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM
OS   14847 / LMG 12228 / 1C / PRS 101 / PAO1).
OC   Bacteria; Pseudomonadota; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=208964;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 2-35, FUNCTION,
RP   INDUCTION, AND SUBUNIT.
RC   STRAIN=PAO;
RX   PubMed=3109911; DOI=10.1111/j.1432-1033.1987.tb13489.x;
RA   Baur H., Stalon V., Falmagne P., Luethi E., Haas D.;
RT   "Primary and quaternary structure of the catabolic ornithine
RT   carbamoyltransferase from Pseudomonas aeruginosa. Extensive sequence
RT   homology with the anabolic ornithine carbamoyltransferases of Escherichia
RT   coli.";
RL   Eur. J. Biochem. 166:111-117(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 /
RC   1C / PRS 101 / PAO1;
RX   PubMed=10984043; DOI=10.1038/35023079;
RA   Stover C.K., Pham X.-Q.T., Erwin A.L., Mizoguchi S.D., Warrener P.,
RA   Hickey M.J., Brinkman F.S.L., Hufnagle W.O., Kowalik D.J., Lagrou M.,
RA   Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y.,
RA   Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R.M.,
RA   Smith K.A., Spencer D.H., Wong G.K.-S., Wu Z., Paulsen I.T., Reizer J.,
RA   Saier M.H. Jr., Hancock R.E.W., Lory S., Olson M.V.;
RT   "Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic
RT   pathogen.";
RL   Nature 406:959-964(2000).
RN   [3]
RP   FUNCTION AS A CATABOLIC OTCASE, BIOPHYSICOCHEMICAL PROPERTIES, AND PATHWAY.
RX   PubMed=4962140; DOI=10.1016/0005-2744(67)90115-5;
RA   Stalon V., Ramos F., Pierard A., Wiame J.M.;
RT   "The occurrence of a catabolic and an anabolic ornithine
RT   carbamoyltransferase in Pseudomonas.";
RL   Biochim. Biophys. Acta 139:91-97(1967).
RN   [4]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND PATHWAY.
RX   PubMed=113384; DOI=10.1128/jb.139.3.713-720.1979;
RA   Hass D., Evans R., Mercenier A., Simon J.P., Stalon V.;
RT   "Genetic and physiological characterization of Pseudomonas aeruginosa
RT   mutants affected in the catabolic ornithine carbamoyltransferase.";
RL   J. Bacteriol. 139:713-720(1979).
RN   [5]
RP   INDUCTION.
RX   PubMed=6252188; DOI=10.1128/jb.144.1.159-163.1980;
RA   Mercenier A., Simon J.P., Vander Wauven C., Haas D., Stalon V.;
RT   "Regulation of enzyme synthesis in the arginine deiminase pathway of
RT   Pseudomonas aeruginosa.";
RL   J. Bacteriol. 144:159-163(1980).
RN   [6]
RP   PATHWAY.
RX   PubMed=6438064; DOI=10.1128/jb.160.3.928-934.1984;
RA   Vander Wauven C., Pierard A., Kley-Raymann M., Haas D.;
RT   "Pseudomonas aeruginosa mutants affected in anaerobic growth on arginine:
RT   evidence for a four-gene cluster encoding the arginine deiminase pathway.";
RL   J. Bacteriol. 160:928-934(1984).
RN   [7]
RP   FUNCTION, AND MUTAGENESIS OF GLU-106.
RX   PubMed=2118516; DOI=10.1016/s0021-9258(18)77171-8;
RA   Baur H., Tricot C., Stalon V., Haas D.;
RT   "Converting catabolic ornithine carbamoyltransferase to an anabolic
RT   enzyme.";
RL   J. Biol. Chem. 265:14728-14731(1990).
RN   [8]
RP   FUNCTION, MUTAGENESIS OF GLU-106, ACTIVITY REGULATION, AND REACTION
RP   MECHANISM.
RX   PubMed=8102605; DOI=10.1111/j.1432-1033.1993.tb18099.x;
RA   Tricot C., Nguyen V.T., Stalon V.;
RT   "Steady-state kinetics and analysis of pH dependence on wild-type and a
RT   modified allosteric Pseudomonas aeruginosa ornithine carbamoyltransferase
RT   containing the replacement of glutamate 105 by alanine.";
RL   Eur. J. Biochem. 215:833-839(1993).
RN   [9]
RP   SUBUNIT.
RX   PubMed=10489456; DOI=10.1107/s0907444999007970;
RA   Sainz G., Vicat J., Kahn R., Tricot C., Stalon V., Dideberg O.;
RT   "Purification, crystallization and preliminary X-ray analysis of catabolic
RT   ornithine carbamoyltransferase from Pseudomonas aeruginosa.";
RL   Acta Crystallogr. D 55:1591-1593(1999).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF MUTANT GLY-106, MUTAGENESIS OF
RP   GLU-106, AND SUBUNIT.
RX   PubMed=7479879; DOI=10.1073/pnas.92.23.10762;
RA   Villeret V., Tricot C., Stalon V., Dideberg O.;
RT   "Crystal structure of Pseudomonas aeruginosa catabolic ornithine
RT   transcarbamoylase at 3.0-A resolution: a different oligomeric organization
RT   in the transcarbamoylase family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:10762-10766(1995).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF MUTANT GLY-106, AND SUBUNIT.
RA   Sainz G., Vicat J., Kahn R., Duee E., Tricot C., Stalon V., Dideberg O.;
RT   "Catabolic ornithine carbamoyltransferase from Pseudomonas aeruginosa.";
RL   Submitted (JAN-2000) to the PDB data bank.
CC   -!- FUNCTION: Involved in the catabolism of arginine. Catalyzes the
CC       phosphorolysis of citrulline, the reverse reaction of the biosynthetic
CC       one, yielding ornithine and carbamoyl phosphate which serve to generate
CC       ATP from ADP (PubMed:2118516, PubMed:4962140). This catabolic OTCase
CC       does not carry out the biosynthetic reaction because of a poor affinity
CC       and a marked cooperativity for carbamoyl phosphate (PubMed:2118516).
CC       {ECO:0000269|PubMed:2118516, ECO:0000269|PubMed:4962140,
CC       ECO:0000305|PubMed:113384, ECO:0000305|PubMed:3109911,
CC       ECO:0000305|PubMed:8102605}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=carbamoyl phosphate + L-ornithine = L-citrulline + phosphate +
CC         H(+); Xref=Rhea:RHEA:19513, ChEBI:CHEBI:15378, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:46911, ChEBI:CHEBI:57743, ChEBI:CHEBI:58228; EC=2.1.3.3;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01109};
CC   -!- ACTIVITY REGULATION: Inhibited by 2-aminopentanoic acid (norvaline).
CC       Activated by phosphate and nucleoside monophosphates such as AMP, GMP,
CC       CMP, UMP. Allosterically inhibited by the polyamines such as spermidine
CC       and putrescine. {ECO:0000269|PubMed:8102605}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 7.3. {ECO:0000269|PubMed:4962140};
CC   -!- PATHWAY: Amino-acid degradation; L-arginine degradation via ADI
CC       pathway; carbamoyl phosphate from L-arginine: step 2/2.
CC       {ECO:0000305|PubMed:113384, ECO:0000305|PubMed:4962140,
CC       ECO:0000305|PubMed:6438064}.
CC   -!- SUBUNIT: Nonameric or dodecamer (tetramer of trimers).
CC       {ECO:0000269|PubMed:10489456, ECO:0000269|PubMed:3109911,
CC       ECO:0000269|PubMed:7479879, ECO:0000269|Ref.11}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.
CC   -!- INDUCTION: During limiting aeration and in the presence of arginine.
CC       {ECO:0000269|PubMed:6252188, ECO:0000305|PubMed:3109911}.
CC   -!- DISRUPTION PHENOTYPE: Cells lacking this gene are blocked in the
CC       arginine deiminase pathway. {ECO:0000269|PubMed:113384}.
CC   -!- MISCELLANEOUS: Proceeds by an ordered sequential mechanism with CP
CC       identified as the initial reactant. {ECO:0000305|PubMed:8102605}.
CC   -!- SIMILARITY: Belongs to the aspartate/ornithine carbamoyltransferase
CC       superfamily. OTCase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X05637; CAA29124.1; -; Genomic_DNA.
DR   EMBL; AE004091; AAG08557.1; -; Genomic_DNA.
DR   PIR; S00032; OWPSCA.
DR   RefSeq; NP_253859.1; NC_002516.2.
DR   RefSeq; WP_003100031.1; NZ_QZGE01000002.1.
DR   PDB; 1DXH; X-ray; 2.50 A; A=2-336.
DR   PDB; 1ORT; X-ray; 3.00 A; A/B/C/D/E/F/G/H/I/J/K/L=2-336.
DR   PDBsum; 1DXH; -.
DR   PDBsum; 1ORT; -.
DR   AlphaFoldDB; P08308; -.
DR   SMR; P08308; -.
DR   STRING; 208964.PA5172; -.
DR   PaxDb; 208964-PA5172; -.
DR   GeneID; 881792; -.
DR   KEGG; pae:PA5172; -.
DR   PATRIC; fig|208964.12.peg.5420; -.
DR   PseudoCAP; PA5172; -.
DR   HOGENOM; CLU_043846_3_1_6; -.
DR   InParanoid; P08308; -.
DR   OrthoDB; 9802587at2; -.
DR   PhylomeDB; P08308; -.
DR   BioCyc; PAER208964:G1FZ6-5289-MONOMER; -.
DR   SABIO-RK; P08308; -.
DR   UniPathway; UPA00254; UER00365.
DR   EvolutionaryTrace; P08308; -.
DR   Proteomes; UP000002438; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016597; F:amino acid binding; IEA:InterPro.
DR   GO; GO:0004585; F:ornithine carbamoyltransferase activity; IMP:PseudoCAP.
DR   GO; GO:0042450; P:arginine biosynthetic process via ornithine; IBA:GO_Central.
DR   GO; GO:0019547; P:arginine catabolic process to ornithine; IEA:UniProtKB-UniPathway.
DR   GO; GO:0019546; P:arginine deiminase pathway; IMP:PseudoCAP.
DR   GO; GO:0019240; P:citrulline biosynthetic process; IBA:GO_Central.
DR   FunFam; 3.40.50.1370:FF:000003; Ornithine carbamoyltransferase; 1.
DR   Gene3D; 3.40.50.1370; Aspartate/ornithine carbamoyltransferase; 2.
DR   HAMAP; MF_01109; OTCase; 1.
DR   InterPro; IPR006132; Asp/Orn_carbamoyltranf_P-bd.
DR   InterPro; IPR006130; Asp/Orn_carbamoylTrfase.
DR   InterPro; IPR036901; Asp/Orn_carbamoylTrfase_sf.
DR   InterPro; IPR006131; Asp_carbamoyltransf_Asp/Orn-bd.
DR   InterPro; IPR002292; Orn/put_carbamltrans.
DR   InterPro; IPR024904; OTCase_ArgI.
DR   NCBIfam; TIGR00658; orni_carb_tr; 1.
DR   PANTHER; PTHR45753:SF2; ORNITHINE CARBAMOYLTRANSFERASE, CATABOLIC; 1.
DR   PANTHER; PTHR45753; ORNITHINE CARBAMOYLTRANSFERASE, MITOCHONDRIAL; 1.
DR   Pfam; PF00185; OTCace; 1.
DR   Pfam; PF02729; OTCace_N; 1.
DR   PRINTS; PR00100; AOTCASE.
DR   PRINTS; PR00102; OTCASE.
DR   SUPFAM; SSF53671; Aspartate/ornithine carbamoyltransferase; 1.
DR   PROSITE; PS00097; CARBAMOYLTRANSFERASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Arginine metabolism; Cytoplasm; Direct protein sequencing;
KW   Reference proteome; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:3109911"
FT   CHAIN           2..336
FT                   /note="Ornithine carbamoyltransferase, catabolic"
FT                   /id="PRO_0000112986"
FT   BINDING         57..60
FT                   /ligand="carbamoyl phosphate"
FT                   /ligand_id="ChEBI:CHEBI:58228"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01109"
FT   BINDING         84
FT                   /ligand="carbamoyl phosphate"
FT                   /ligand_id="ChEBI:CHEBI:58228"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01109"
FT   BINDING         108
FT                   /ligand="carbamoyl phosphate"
FT                   /ligand_id="ChEBI:CHEBI:58228"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01109"
FT   BINDING         135..138
FT                   /ligand="carbamoyl phosphate"
FT                   /ligand_id="ChEBI:CHEBI:58228"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01109"
FT   BINDING         168
FT                   /ligand="L-ornithine"
FT                   /ligand_id="ChEBI:CHEBI:46911"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01109"
FT   BINDING         232
FT                   /ligand="L-ornithine"
FT                   /ligand_id="ChEBI:CHEBI:46911"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01109"
FT   BINDING         236..237
FT                   /ligand="L-ornithine"
FT                   /ligand_id="ChEBI:CHEBI:46911"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01109"
FT   BINDING         274..275
FT                   /ligand="carbamoyl phosphate"
FT                   /ligand_id="ChEBI:CHEBI:58228"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01109"
FT   BINDING         321
FT                   /ligand="carbamoyl phosphate"
FT                   /ligand_id="ChEBI:CHEBI:58228"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01109"
FT   MUTAGEN         106
FT                   /note="E->A,G: Loss of homotropic cooperativity; gain of
FT                   anabolic activity. Conformational change which modifies the
FT                   catalytic site. This mutant is blocked in the active R
FT                   (relaxed) state."
FT                   /evidence="ECO:0000269|PubMed:2118516,
FT                   ECO:0000269|PubMed:7479879, ECO:0000269|PubMed:8102605"
FT   STRAND          10..13
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   HELIX           18..36
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   STRAND          48..55
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   HELIX           58..70
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   STRAND          74..78
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   TURN            80..82
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   TURN            85..87
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   HELIX           91..101
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   STRAND          103..108
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   HELIX           112..121
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   STRAND          122..124
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   STRAND          126..130
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   HELIX           136..148
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   HELIX           154..156
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   STRAND          158..163
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   HELIX           168..179
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   STRAND          183..187
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   HELIX           190..192
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   HELIX           196..209
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   STRAND          212..217
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   HELIX           219..222
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   TURN            223..225
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   STRAND          227..231
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   STRAND          237..239
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   HELIX           241..243
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   HELIX           245..251
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   HELIX           252..254
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   HELIX           258..262
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   STRAND          270..273
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   STRAND          280..283
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   HELIX           284..292
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   HELIX           294..298
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   STRAND          299..303
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   HELIX           304..307
FT                   /evidence="ECO:0007829|PDB:1DXH"
FT   STRAND          309..312
FT                   /evidence="ECO:0007829|PDB:1ORT"
FT   HELIX           314..333
FT                   /evidence="ECO:0007829|PDB:1DXH"
SQ   SEQUENCE   336 AA;  38109 MW;  4E780414EADA4724 CRC64;
     MAFNMHNRNL LSLMHHSTRE LRYLLDLSRD LKRAKYTGTE QQHLKRKNIA LIFEKTSTRT
     RCAFEVAAYD QGANVTYIDP NSSQIGHKES MKDTARVLGR MYDAIEYRGF KQEIVEELAK
     FAGVPVFNGL TDEYHPTQML ADVLTMREHS DKPLHDISYA YLGDARNNMG NSLLLIGAKL
     GMDVRIAAPK ALWPHDEFVA QCKKFAEESG AKLTLTEDPK EAVKGVDFVH TDVWVSMGEP
     VEAWGERIKE LLPYQVNMEI MKATGNPRAK FMHCLPAFHN SETKVGKQIA EQYPNLANGI
     EVTEDVFESP YNIAFEQAEN RMHTIKAILV STLADI
//
